Substance

ID:1826053

Names and Identifiers
IUPAC name
(2S)-1-[(2S)-5-carbamimidamido-2-[(2S)-2-[(2R)-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-2-[(2S)-3-(1H-imidazol-4-yl)-2-{[(2S)-5-oxopyrrolidin-2-yl]formamido}propanamido]-3-(1H-indol-3-yl)propanamido]propanamido]-3-(4-hydroxyphenyl)propanamido]-4-methylpentanamido]-4-methylpentanamido]pentanoyl]-N-ethylpyrrolidine-2-carboxamide
IUPAC Traditional name
leuprorelin
Synonyms
leuprolide(D-Leu(6),des-Gly-NH2(10),Pro-ethylamide(9))-gonadotropin-releasing hormoneL-pyroglutamyl-L-histidyl-L-tryptophyl-L-seryl-L-tyrosyl-D-leucyl-L-leucyl-L-arginyl-L-proline ethylamideLeuprorelinpGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHC2H5pGlu-His-Trp-Ser-Tyr-D-Leu-Leu-Arg-Pro-NHEt
International Nonproprietary Name (INN)
leuprorelinaleuprorelineleuprorelinum
Registration numbers
PubChem CID
CAS Number
KEGG ID
Reaxys Registry
CompTox Database
MetaboLights Database
SureChEMBL Database
Patent number
DrugBank ID
Drug Central Database
KEGG DRUG Database
CHEBI ID
PubChem SID
Properties
No Data Available
Click here to submit data
Molecule Details
An oligopeptide comprising pyroglutamyl, histidyl, tryptophyl, seryl, tyrosyl, D-leucyl, leucyl, arginyl, and N-ethylprolinamide residues joined in sequence. It is a synthetic nonapeptide analogue of gonadotropin-releasing hormone, and is used as a subcutaneous hydrogel implant (particularly as the acetate salt) for the treatment of prostate cancer and for the suppression of gonadal sex hormone production in children with central precocious puberty.
Molecular Spectra
No Data Available
Click here to submit data
References
No Data Available
Click here to submit data